39 min

CBD: Beyond the Basics with Cannabinoid Researcher Hunter Land Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

    • Mental Health

Hunter Land is the director of cannabinoid research at Canopy Growth Corporation. He has devoted his career to researching cannabis-derived medicines and their application across a variety of conditions, leading the clinical development of the first FDA-approved CBD medication, Epidiolex.
In this episode, Hunter shares the science-based reality of dosing guidelines for using CBD for various conditions and purposes. He answers questions regarding sublingual delivery, whether you can develop tolerance to CBD, the difference between broad-spectrum full-spectrum CBD, and much more.
 
In this episode:
The difficulty in establishing CBD dosing guidelines. A discussion of whether one can develop tolerance to CBD What to look for when choosing a CBD product. Whether the long-term use of cannabis affects CBD effectivity

Quotes:
“It’s tough to come up and say: “well you need this amount for sleep, you need this amount for anxiety, you need this amount for epilepsy.” So, with a lot of other medications, a lot of physicians, like yourself, probably know, it’s not uncommon to start low and go slow and see where you might land.” [5:00]
“At low doses, we do think there might be some enhanced stimulation effect. But we also know it’s not like a stimulant like amphetamine or caffeine. It seems to function differently than that.” [6:20]
“We don’t have guidance on pesticides either. So I think beyond just knowing what’s in products based on standardization techniques, also what contaminates could be present is also of importance.” [25:40]
 
Links:
Get 20% off everything at Octagon Biolabs with coupon code 'plantmedicine'
Canopy Growth Corp
Follow The Plant Medicine Podcast on Instagram
Porangui

Hunter Land is the director of cannabinoid research at Canopy Growth Corporation. He has devoted his career to researching cannabis-derived medicines and their application across a variety of conditions, leading the clinical development of the first FDA-approved CBD medication, Epidiolex.
In this episode, Hunter shares the science-based reality of dosing guidelines for using CBD for various conditions and purposes. He answers questions regarding sublingual delivery, whether you can develop tolerance to CBD, the difference between broad-spectrum full-spectrum CBD, and much more.
 
In this episode:
The difficulty in establishing CBD dosing guidelines. A discussion of whether one can develop tolerance to CBD What to look for when choosing a CBD product. Whether the long-term use of cannabis affects CBD effectivity

Quotes:
“It’s tough to come up and say: “well you need this amount for sleep, you need this amount for anxiety, you need this amount for epilepsy.” So, with a lot of other medications, a lot of physicians, like yourself, probably know, it’s not uncommon to start low and go slow and see where you might land.” [5:00]
“At low doses, we do think there might be some enhanced stimulation effect. But we also know it’s not like a stimulant like amphetamine or caffeine. It seems to function differently than that.” [6:20]
“We don’t have guidance on pesticides either. So I think beyond just knowing what’s in products based on standardization techniques, also what contaminates could be present is also of importance.” [25:40]
 
Links:
Get 20% off everything at Octagon Biolabs with coupon code 'plantmedicine'
Canopy Growth Corp
Follow The Plant Medicine Podcast on Instagram
Porangui

39 min